Treatment adherence behaviours in rheumatic diseases during COVID-19 pandemic: a Latin American experience
- PMID: 32576568
- DOI: 10.1136/annrheumdis-2020-218198
Treatment adherence behaviours in rheumatic diseases during COVID-19 pandemic: a Latin American experience
Keywords: antirheumatic agents; autoimmune diseases; hydroxychloroquine; therapeutics.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Treatment adherence behaviours in rheumatic diseases during pandemic COVID-19: a Latin American experience' by Pineda-Sic et al.Ann Rheum Dis. 2021 Jun;80(6):e86. doi: 10.1136/annrheumdis-2020-218223. Epub 2020 Jun 23. Ann Rheum Dis. 2021. PMID: 32576567 No abstract available.
-
Adherence to medication in patients with rheumatic diseases during COVID-19 pandemic.Ann Rheum Dis. 2022 Oct;81(10):e200. doi: 10.1136/annrheumdis-2020-218756. Epub 2020 Sep 7. Ann Rheum Dis. 2022. PMID: 32895235 No abstract available.
-
Education and treatment adherence during the COVID-19 pandemic. Response to: 'Adherence to medication in patients with rheumatic diseases during COVID-19 pandemic' by Khabbazi et al.Ann Rheum Dis. 2022 Oct;81(10):e201. doi: 10.1136/annrheumdis-2020-218791. Epub 2020 Sep 7. Ann Rheum Dis. 2022. PMID: 32895238 No abstract available.
Comment on
-
Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic.Ann Rheum Dis. 2020 Jun;79(6):840-842. doi: 10.1136/annrheumdis-2020-217628. Epub 2020 Apr 28. Ann Rheum Dis. 2020. PMID: 32345619 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
